Results from the Phase I trial in humans of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a Synopsis

One of the vaccine candidates for COVID-19 at the Phase I stage is the non-replicating adenovirus type-5 (Ad5) vectored COVID-19 vaccine developed by the Beijing Institute of Biotechnology (Beijing, Read More…

Summary of Updated data from the French Chloroquine/Azithromycin Study for Covid-19, Summarized by Nana Dadzie Ghansah

The French group in Marseille whose small study really got the ball rolling on using hydroxychloroquine and azithromycin to treat COVID-19 released data on 80 more patients. Six of those were from thRead More…